顺铂和依托泊苷治疗非小细胞肺癌 - Suppr

Suppr

超能文献

Therapy with cisplatin and etoposide for non-small-cell lung cancer.

作者信息

Klastersky J

出版信息

Semin Oncol. 1986 Sep;13(3 Suppl 3):104-14.

PMID:3020693

Abstract

摘要

相似文献

Therapy with cisplatin and etoposide for non-small-cell lung cancer.顺铂和依托泊苷治疗非小细胞肺癌

Semin Oncol. 1986 Sep;13(3 Suppl 3):104-14.

Clinical trials referral resource. Non-small-cell lung cancer.

Oncology (Williston Park). 1992 Jul;6(7):44, 49-50.

Etoposide/ifosfamide/cisplatin regimens in metastatic non-small cell lung cancer.

Semin Oncol. 1994 Jun;21(3 Suppl 4):2-5.

Etoposide, ifosfamide, and cisplatin in the treatment of advanced non-small cell lung cancer.依托泊苷、异环磷酰胺和顺铂治疗晚期非小细胞肺癌。

Cancer Treat Rep. 1987 Dec;71(12):1311-2.

[Comparative study of 2 doses of cisplatin combined with etoposide in the treatment of non-small cell carcinoma of the lung].

G Ital Chemioter. 1986 May-Dec;33(2-3):157-60.

Induction chemotherapy with cisplatin, etoposide and vindesine before radiation therapy for nonsmall-cell lung cancer. A randomized study.非小细胞肺癌放疗前顺铂、依托泊苷和长春地辛诱导化疗：一项随机研究。

Antibiot Chemother (1971). 1988;41:131-7. doi: 10.1159/000416193.

Cisplatin and carboplatin in combination with etoposide as a treatment for non-small cell lung cancer: the experience of the EORTC Lung Cancer Working Party.顺铂和卡铂联合依托泊苷治疗非小细胞肺癌：欧洲癌症研究与治疗组织肺癌工作组的经验

Cancer Treat Rev. 1988 Jun;15 Suppl B:33-40. doi: 10.1016/0305-7372(88)90032-1.

[Treatment of non-small cell cancer of the lung with a combination of cisplatin-VP-16 and mitomycin C].顺铂-依托泊苷与丝裂霉素C联合治疗非小细胞肺癌

Rev Med Chil. 1987 Jan;115(1):31-6.

Trimetrexate combined with cisplatin or etoposide in the treatment of non-small cell lung cancer: a pilot study.三甲曲沙联合顺铂或依托泊苷治疗非小细胞肺癌：一项初步研究。

Semin Oncol. 1988 Apr;15(2 Suppl 2):38-40.

[Irinotecan].[伊立替康]

Nihon Rinsho. 2002 May;60 Suppl 5:339-42.

引用本文的文献

Randomized, multi-center phase II trial of docetaxel plus cisplatin versus etoposide plus cisplatin as the first-line therapy for patients with advanced non-small cell lung cancer.多中心随机 II 期临床试验：多西他赛联合顺铂对比依托泊苷联合顺铂作为晚期非小细胞肺癌一线治疗。

Cancer Res Treat. 2005 Dec;37(6):332-8. doi: 10.4143/crt.2005.37.6.332. Epub 2005 Dec 31.

Adaptive intrapatient dose escalation of cisplatin in combination with low-dose vp16 in patients with nonsmall cell lung cancer.顺铂联合低剂量依托泊苷对非小细胞肺癌患者进行适应性患者内剂量递增治疗。

Br J Cancer. 2003 Mar 24;88(6):814-21. doi: 10.1038/sj.bjc.6600794.

Phase II study of a 72-h concurrent continuous infusion of cisplatin and etoposide in advanced non-small-cell lung cancer.顺铂与依托泊苷72小时持续静脉滴注同步治疗晚期非小细胞肺癌的II期研究

Cancer Chemother Pharmacol. 1993;32(2):134-6. doi: 10.1007/BF00685616.

Carboplatin in combination with etoposide in inoperable non-small-cell lung cancer (NSCLC).

Med Oncol Tumor Pharmacother. 1990;7(4):219-22. doi: 10.1007/BF02987098.

Phase II study of carboplatin in untreated, inoperable non-small-cell lung cancer.

Cancer Chemother Pharmacol. 1990;26(5):369-72. doi: 10.1007/BF02897296.

Pharmacokinetics and toxicity of two modalities of etoposide infusion in metastatic non-small-cell lung carcinoma.

Cancer Chemother Pharmacol. 1990;26(5):365-8. doi: 10.1007/BF02897295.

Phase II study of mitomycin C, etoposide and vindesine in metastatic stage IV non-small-cell lung cancer.

Cancer Chemother Pharmacol. 1991;28(5):405-7. doi: 10.1007/BF00685698.

Mitomycin C plus vindesine or cisplatin plus epirubicin in previously treated patients with symptomatic advanced non-small-cell lung cancer.丝裂霉素C加长春地辛或顺铂加表柔比星用于先前接受过治疗的有症状的晚期非小细胞肺癌患者。

Cancer Chemother Pharmacol. 1992;30(3):212-4. doi: 10.1007/BF00686314.

A prognostic-factor risk index in advanced non-small-cell lung cancer treated with cisplatin-containing combination chemotherapy.含顺铂联合化疗治疗晚期非小细胞肺癌的预后因素风险指数

Cancer Chemother Pharmacol. 1992;30(1):1-6. doi: 10.1007/BF00686477.

Vinorelbine. A review of its antitumour activity in lung cancer.长春瑞滨。其在肺癌中抗肿瘤活性的综述。

Drugs. 1992;44 Suppl 4:60-5; discussion 66-9. doi: 10.2165/00003495-199200444-00007.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验